Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 11344092)

Published in FASEB J on May 01, 2001

Authors

G S Robinson1, M Ju, S C Shih, X Xu, G McMahon, R B Caldwell, L E Smith

Author Affiliations

1: Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

Articles citing this

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol (2007) 3.93

Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors. PLoS One (2008) 3.46

Vascular endothelial growth factor in eye disease. Prog Retin Eye Res (2008) 2.73

Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med (2009) 2.12

Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A. Blood (2011) 2.02

Targeted deletion of Vegfa in adult mice induces vision loss. J Clin Invest (2012) 1.79

Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am J Pathol (2002) 1.62

VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm. Neuron (2011) 1.58

Molecular profiling of angiogenesis markers. Am J Pathol (2002) 1.57

Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol (2003) 1.50

Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J Clin Invest (2003) 1.50

Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog. Invest Ophthalmol Vis Sci (2011) 1.33

Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity. Mol Vis (2008) 1.29

Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword. Adv Exp Med Biol (2004) 1.17

Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy. Glia (2010) 1.15

Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials. Exp Eye Res (2006) 1.14

VEGF in the nervous system. Organogenesis (2010) 1.13

Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP. Exp Eye Res (2009) 1.11

Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo. Proc Natl Acad Sci U S A (2003) 1.03

Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye. Trends Mol Med (2014) 1.00

Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye. PLoS One (2011) 0.95

Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis. BMC Syst Biol (2011) 0.94

Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk. J Clin Invest (2014) 0.92

Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491. BMC Pediatr (2010) 0.86

Functional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuity. Clin Ophthalmol (2007) 0.84

Expression and role of VEGF--a in the ciliary body. Invest Ophthalmol Vis Sci (2012) 0.83

Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells. Br J Ophthalmol (2006) 0.82

Topoisomerase IIbeta is required for proper retinal development and survival of postmitotic cells. Biol Open (2014) 0.81

Brain homeostasis: VEGF receptor 1 and 2-two unequal brothers in mind. Cell Mol Life Sci (2013) 0.80

Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration. Am J Ophthalmol (2014) 0.80

Epithelial-mesenchymal transition of the retinal pigment epithelium causes choriocapillaris atrophy. Histochem Cell Biol (2016) 0.79

Truncated netrin-1 contributes to pathological vascular permeability in diabetic retinopathy. J Clin Invest (2016) 0.79

Neurodevelopmental Outcomes in Infants with Retinopathy of Prematurity and Bevacizumab Treatment. PLoS One (2016) 0.77

Hyperoxia-Induced Proliferative Retinopathy: Early Interruption of Retinal Vascular Development with Severe and Irreversible Neurovascular Disruption. PLoS One (2016) 0.75

Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications. Am J Physiol Heart Circ Physiol (2016) 0.75

Animal models of ocular angiogenesis: from development to pathologies. FASEB J (2017) 0.75

Review of effects of anti-VEGF treatment on refractive error. Eye Brain (2016) 0.75

Articles by these authors

An association between air pollution and mortality in six U.S. cities. N Engl J Med (1993) 38.84

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science (1998) 19.40

Interleukin-13: central mediator of allergic asthma. Science (1998) 14.05

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol (2000) 13.29

Implementing a unified approach to family-based tests of association. Genet Epidemiol (2000) 10.96

The family based association test method: strategies for studying general genotype--phenotype associations. Eur J Hum Genet (2001) 9.09

Cell transformation by the superoxide-generating oxidase Mox1. Nature (1999) 6.23

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A (1995) 5.92

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A (1995) 5.66

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science (1997) 4.70

SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res (1999) 4.23

Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene (2001) 3.97

Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg (1996) 3.76

Functional interaction between InsP3 receptors and store-operated Htrp3 channels. Nature (1998) 3.68

Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol (1996) 3.49

Association between air pollution and low birth weight: a community-based study. Environ Health Perspect (1997) 3.32

Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J (2001) 3.24

TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol (2001) 3.22

FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development (1998) 3.21

Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem (1995) 3.13

Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia (2005) 3.10

Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes (1997) 3.08

Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity (1995) 3.07

Actin filament disassembly is a sufficient final trigger for exocytosis in nonexcitable cells. J Cell Biol (1995) 2.90

Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem (2000) 2.86

The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80

Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med (1999) 2.74

Antibody catalysis of the oxidation of water. Science (2001) 2.74

Vascular endothelial growth factor in eye disease. Prog Retin Eye Res (2008) 2.73

Complete genome sequence of the shrimp white spot bacilliform virus. J Virol (2001) 2.58

The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad Sci U S A (1998) 2.51

E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo. Cell (2001) 2.50

The complete mitochondrial genome of the wallaroo (Macropus robustus) and the phylogenetic relationship among Monotremata, Marsupialia, and Eutheria. Proc Natl Acad Sci U S A (1997) 2.40

A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene (1998) 2.39

SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res (2000) 2.39

Patterns of condom use among adolescents: the impact of mother-adolescent communication. Am J Public Health (1998) 2.37

Roles for Fgf signaling during zebrafish fin regeneration. Dev Biol (2000) 2.36

Polarized expression of Ca2+ channels in pancreatic and salivary gland cells. Correlation with initiation and propagation of [Ca2+]i waves. J Biol Chem (1997) 2.35

Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans. J Med Virol (2002) 2.35

Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A (2001) 2.35

Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development (1999) 2.34

Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice. Oncogene (2001) 2.33

Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci U S A (1996) 2.31

Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem (1999) 2.18

BMA approves acupuncture. BMA report is wrong. BMJ (2000) 2.16

Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res (1998) 2.16

The future of genetic case-control studies. Adv Genet (2001) 2.11

Separation of subcellular compartments containing distinct functional forms of MHC class II. J Cell Biol (1994) 2.09

A unified Haseman-Elston method for testing linkage with quantitative traits. Am J Hum Genet (2000) 2.08

Detection and surveillance of colorectal cancer. JAMA (1989) 2.07

Dietary phytoestrogens. Annu Rev Nutr (1997) 2.07

Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection. Antimicrob Agents Chemother (1999) 2.06

Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals. J Virol (1997) 2.00

Substrate-induced magnetic ordering and switching of iron porphyrin molecules. Nat Mater (2007) 1.98

Characterization of c-Ki-ras oncogene alleles by direct sequencing of enzymatically amplified DNA from carcinogen-induced tumors. Proc Natl Acad Sci U S A (1987) 1.98

The relationship between opsin overexpression and photoreceptor degeneration. Invest Ophthalmol Vis Sci (2001) 1.98

Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene (2012) 1.95

Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. Proc Natl Acad Sci U S A (1998) 1.94

Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses. J Gen Virol (1993) 1.92

Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J (2001) 1.86

Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. Curr Biol (1999) 1.85

Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B. Science (1992) 1.85

Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet (1998) 1.82

Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. Cancer Res (2001) 1.80

SC35 plays a role in T cell development and alternative splicing of CD45. Mol Cell (2001) 1.76

Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J Biol Chem (1994) 1.76

Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma. Hum Genet (1998) 1.75

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J Am Coll Cardiol (1999) 1.74

Risk factors for oesophageal cancer in northeast China. Int J Cancer (1994) 1.73

Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. J Med Chem (1999) 1.70

An influenza A (H1N1) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza. J Virol (1994) 1.65

Genetic diversity in the northernmost Oryza rufipogon populations estimated by SSR markers. Theor Appl Genet (2003) 1.65

Complications in colonoscopy. Dis Colon Rectum (1975) 1.64

Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. Am J Respir Crit Care Med (1995) 1.62

A murine model for assessment of living attenuated influenza A vaccines. Aust J Exp Biol Med Sci (1980) 1.62

Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d. Nature (1998) 1.61

Prospective study of exposure to environmental tobacco smoke and dysmenorrhea. Environ Health Perspect (2000) 1.60

Cardiovascular diseases: oxidative damage and antioxidant protection. Eur Rev Med Pharmacol Sci (2014) 1.59

Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res (1994) 1.57

Fiberoptic colonoscopy: complications of colonoscopy and polypectomy. Dis Colon Rectum (1976) 1.57

FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development. Development (2000) 1.57

Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. Invest Ophthalmol Vis Sci (2001) 1.57

Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis (1995) 1.57

ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation (1997) 1.56

Flk-1 as a target for tumor growth inhibition. Cancer Res (1996) 1.56

SNPkit: an efficient approach to systematic evaluation of candidate single nucleotide polymorphisms in public databases. Biotechniques (2002) 1.55

Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res (2001) 1.55

Bronchial compression as a result of lung herniation after pneumonectomy. Thorax (1991) 1.53

A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum Mol Genet (2000) 1.53

VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun (1999) 1.53

Forensic palaeontology: The Archaeoraptor forgery. Nature (2001) 1.53

Bioefficacy of beta-carotene dissolved in oil studied in children in Indonesia. Am J Clin Nutr (2001) 1.52

Genetic susceptibility to benzene and shortened gestation: evidence of gene-environment interaction. Am J Epidemiol (2000) 1.52

Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J Med Chem (1998) 1.52

In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol (2000) 1.51

The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling. J Biol Chem (1998) 1.51

Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis (1992) 1.50

Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse. Microvasc Res (1993) 1.50

Normal aging in the basal ganglia evaluated by eigenvalues of diffusion tensor imaging. AJNR Am J Neuroradiol (2009) 1.49